Treatment of Rheumatoid Arthritis With Roxithromycin

Summary

The purpose of this study is to evaluate the clinical efficacy, safety, and tolerability of roxithromycin in patients with rheumatoid arthritis.

Timeline

Start

2006-06

Primary completion

—

Completion

2006-06

Outcome

Met primary endpoint

paper ACR20 response) at 6 months compared with patients who received placebo (60% vs 34%; P = 0.009). PMID 21904105 ↗

Publications

• Ogrendik M, Karagoz N. Treatment of rheumatoid arthritis with roxithromycin: a randomized trial. Postgrad Med. 2011 Sep;123(5):220-7. doi: 10.3810/pgm.2011.09.2478.

Drugs

Indications